Showing results (131-140 of 175) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against CancerHamza Mameri, Ivan Bièche, Didier Meseure, et al.Biorxiv : the Preprint Server for Biology|April 28, 2025
Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinomaAnjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.Bioinformatics (Oxford, England)|July 31, 2007
AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe setsHongfang Liu, Barry R Zeeberg, Gang Qu, et al.Oncogene|July 19, 2011
CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer InstituteG Zoppoli, S Solier, W C Reinhold, et al.Plos One|July 18, 2014
NCI-60 whole exome sequencing and pharmacological CellMiner analysesWilliam C Reinhold, Sudhir Varma, Fabricio Sousa, et al.Cancers|July 12, 2025
Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical CarcinomaAnjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.Genome Research|September 14, 2019
A novel assay to screen siRNA libraries identifies protein kinases required for chromosome transmissionMikhail Liskovykh, Nikolay V Goncharov, Nikolai Petrov, et al.Molecular Cancer Research : MCR|May 29, 2021
R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor RomidepsinMaryam Safari, Thomas Litman, Robert W Robey, et al.Molecular Cancer Therapeutics|January 12, 2008
MicroRNAs modulate the chemosensitivity of tumor cellsPaul E Blower, Ji-Hyun Chung, Joseph S Verducci, et al.Molecular Cancer Therapeutics|October 15, 2008
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell linesPhilip L Lorenzi, Jenny Llamas, Michele Gunsior, et al.Pageof 18